Compare PNFP & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNFP | PEN |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United States | United States |
| Employees | 3595 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 12.9B |
| IPO Year | N/A | 2015 |
| Metric | PNFP | PEN |
|---|---|---|
| Price | $98.49 | $333.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 17 |
| Target Price | $111.20 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 1.2M | 548.7K |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.09% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $160.52 | $14.34 |
| Revenue Next Year | $9.24 | $13.71 |
| P/E Ratio | ★ $12.24 | $73.42 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $81.08 | $221.26 |
| 52 Week High | $120.39 | $362.41 |
| Indicator | PNFP | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 67.56 | 52.22 |
| Support Level | $92.97 | $326.58 |
| Resistance Level | $101.94 | $336.01 |
| Average True Range (ATR) | 2.44 | 2.27 |
| MACD | 0.89 | 0.43 |
| Stochastic Oscillator | 91.58 | 72.14 |
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.